Показано 0 из 0
Дата |
---|
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.114
|
1.134
|
1.158
|
1.112
|
1.16
|
1.16
|
|
1.14
|
76 277.78
|
27.00
|
1.15
|
1.158
|
1.298
|
1.15
|
1.298
|
1.158
|
|
1.16
|
109 426.12
|
40.00
|
1.16
|
1.17
|
1.262
|
1.15
|
1.28
|
1.17
|
|
1.19
|
173 339.96
|
70.00
|
1.18
|
1.202
|
1.136
|
1.124
|
1.266
|
1.262
|
|
1.16
|
101 887.77
|
34.00
|
1.124
|
1.142
|
1.12
|
1.092
|
1.16
|
1.124
|
|
1.12
|
107 019.08
|
47.00
|
1.104
|
1.118
|
1.164
|
1.10
|
1.164
|
1.12
|
|
1.13
|
52 872.89
|
31.00
|
1.142
|
1.164
|
1.156
|
1.12
|
1.168
|
1.164
|
|
1.14
|
239 586.53
|
76.00
|
1.132
|
1.156
|
1.222
|
1.006
|
1.222
|
1.156
|
|
1.13
|
1 383 735.79
|
438.00
|
1.674
|
1.70
|
1.748
|
1.666
|
1.75
|
1.70
|
|
1.71
|
214 261.53
|
74.00
|
1.722
|
1.75
|
1.834
|
1.698
|
1.834
|
1.75
|
|
1.74
|
386 041.31
|
85.00
|
Alzinova AB is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer's disease. The company is also engaged in development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody.